Genetic Technologies Ltd has released a press release.
License Agreement to Develop Colorectal Cancer Risk Test
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Quarterly Activities Report & Appendix 4C, 30 September 2016
- Appendix 4E & Financial Report 2016
- Quarterly Activities Report & Appendix 4C - 30 June 2016
- New Generation Test - BREVAGenplus Launch
- Appendix 4D and 31 December 2015 Half Year Financial Report
Later from Genetic Technologies
- AUD 8.1 Million Capital Raising
- Quarterly Activities Report & Appendix 4C - 31 December 2016
- Appendix 4D and 31 December 2016 Half Year Financial Report
- Partnership to Promote BREVAGenplus, Second Year
- Change in Pricing and Billing Program
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies